300347 泰格医药
已收盘 08-04 15:00:00
资讯
新帖
简况
易方达基金增持泰格医药(03347)118.16万股 每股作价约55.91港元
智通财经 · 08-04 18:44
易方达基金增持泰格医药(03347)118.16万股 每股作价约55.91港元
易方达基金减持泰格医药(03347.HK)27.31万股 每股作价约50.05港元
智通财经 · 07-29
易方达基金减持泰格医药(03347.HK)27.31万股 每股作价约50.05港元
全市场独家品种·创新药ETF天弘(517380)飙涨4.56%，涨幅位居全市场第一
格隆汇 · 07-29
全市场独家品种·创新药ETF天弘(517380)飙涨4.56%，涨幅位居全市场第一
港股异动 | 泰格医药(03347.HK)涨超3% 附属拟购买日本MICRON 56.37%股权 深度拓展日本及亚太业务布局
智通财经 · 07-29
港股异动 | 泰格医药(03347.HK)涨超3% 附属拟购买日本MICRON 56.37%股权 深度拓展日本及亚太业务布局
泰格医药宣布收购日本CRO公司Micron
格隆汇 · 07-29
泰格医药宣布收购日本CRO公司Micron
泰格医药(03347.HK)股东曹晓春拟减持公司股份不超过300万股
智通财经 · 07-28
泰格医药(03347.HK)股东曹晓春拟减持公司股份不超过300万股
泰格医药(03347)附属拟2347.71万元购买日本MICRON 56.37%股权
智通财经 · 07-28
泰格医药(03347)附属拟2347.71万元购买日本MICRON 56.37%股权
泰格医药最新公告：持股5%以上股东曹晓春拟减持不超过300万股
证券之星 · 07-28
泰格医药最新公告：持股5%以上股东曹晓春拟减持不超过300万股
易方达基金减持泰格医药(03347)42.41万股 每股作价约50.43港元
智通财经 · 07-28
易方达基金减持泰格医药(03347)42.41万股 每股作价约50.43港元
易方达基金增持泰格医药(03347)37万股 每股作价约49.98港元
智通财经 · 07-22
易方达基金增持泰格医药(03347)37万股 每股作价约49.98港元
泰格医药：完成开源大模型DeepSeek-R1本地化部署
证券之星 · 07-18
泰格医药：完成开源大模型DeepSeek-R1本地化部署
泰格医药最新公告：出售参股公司礼新医药股权
证券之星 · 07-17
泰格医药最新公告：出售参股公司礼新医药股权
CRO概念盘中跳水，泰格医药跌0.10%
市场透视 · 07-16
CRO概念盘中跳水，泰格医药跌0.10%
健康中国概念盘中拉升，泰格医药涨3.70%
市场透视 · 07-08
健康中国概念盘中拉升，泰格医药涨3.70%
中证万得生物科技指数上涨2.24%，前十大权重包含泰格医药等
金融界 · 07-03
中证万得生物科技指数上涨2.24%，前十大权重包含泰格医药等
泰格医药：公司及所投基金对创新生物制药及医疗器械初创企业进行少数股权投资
证券之星 · 07-03
泰格医药：公司及所投基金对创新生物制药及医疗器械初创企业进行少数股权投资
【创新药板块探底回升，昭衍新药涨停】创新药板块探底回升，昭衍新药涨停，艾迪药业涨超6%，泰格医药、凯莱英、舒泰神跟涨。
金融界 · 06-30
【创新药板块探底回升，昭衍新药涨停】创新药板块探底回升，昭衍新药涨停，艾迪药业涨超6%，泰格医药、凯莱英、舒泰神跟涨。
中证万得生物科技指数上涨1.36%，前十大权重包含泰格医药等
金融界 · 06-24
中证万得生物科技指数上涨1.36%，前十大权重包含泰格医药等
泰格医药：2024年7月，公司完成了对日本CRO公司Medical Edge Co., Ltd.的收购
证券之星 · 06-20
泰格医药：2024年7月，公司完成了对日本CRO公司Medical Edge Co., Ltd.的收购
泰格医药新注册《基于Word的翻译文档字数统计工具软件V1.0》项目的软件著作权
证券之星 · 06-18
泰格医药新注册《基于Word的翻译文档字数统计工具软件V1.0》项目的软件著作权
加载更多
公司概况
公司名称：
杭州泰格医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2012-08-17
主营业务：
杭州泰格医药科技股份有限公司的主营业务是为新药研发提供临床试验全过程专业服务的合同研究组织（CRO），为全球医药和医疗器械创新企业提供全面而综合的临床研究解决方案。公司的主要产品是临床运营、临床药理、注册与法规事务、科学事务、医学翻译、药物警戒、真实世界研究、第三方稽查与培训、数据管理及统计分析、临床试验现场管理、受试者招募、医学影像以及实验室。
发行价格：
37.88
{"stockData":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":66.18,"timestamp":1754291028000,"preClose":67.01,"halted":0,"volume":18485032,"delay":0,"changeRate":-0.0124,"floatShares":566000000,"shares":861000000,"eps":0.3897,"marketStatus":"已收盘","change":-0.83,"latestTime":"08-04 15:00:00","open":66.01,"high":66.47,"low":63.17,"amount":1206000000,"amplitude":0.0492,"askPrice":66.19,"askSize":1,"bidPrice":66.18,"bidSize":16,"shortable":0,"etf":0,"ttmEps":0.3897,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1754357400000},"marketStatusCode":5,"adr":0,"adjPreClose":67.01,"symbolType":"stock","openAndCloseTimeList":[[1754271000000,1754278200000],[1754283600000,1754290800000]],"highLimit":73.71,"lowLimit":60.31,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":861026050,"isCdr":false,"pbRate":2.81,"roa":"--","peRate":169.822941,"roe":"0.8%","epsLYR":0.47,"committee":0.530864,"marketValue":56983000000,"turnoverRate":0.0326,"status":1,"hkstockBrief":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":53.3,"timestamp":1754294912006,"preClose":53.9,"halted":0,"volume":2951736,"delay":0,"premium":"-26.31"},"floatMarketCap":37472000000},"requestUrl":"/m/hq/s/300347","defaultTab":"news","newsList":[{"id":"2556835693","title":"易方达基金增持泰格医药(03347)118.16万股 每股作价约55.91港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556835693","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556835693?lang=zh_cn&edition=full","pubTime":"2025-08-04 18:44","pubTimestamp":1754304245,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月29日，易方达基金管理有限公司增持泰格医药(03347)118.16万股，每股作价55.9087港元，总金额约为6606.17万港元。增持后最新持股数目为1380.33万股，持股比例为11.21%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1325451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1820825898.SGD","03347","BK1576","BK0077","BK1141","BK0216","BK1583","300347","LU1146622755.USD","BK0174","BK0028"],"gpt_icon":0},{"id":"2555503014","title":"易方达基金减持泰格医药(03347.HK)27.31万股 每股作价约50.05港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555503014","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555503014?lang=zh_cn&edition=full","pubTime":"2025-07-29 18:40","pubTimestamp":1753785629,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0216","BK1576","BK1583","BK1141","LU1820825898.SGD","LU1146622755.USD","BK0174","BK0077","300347","03347","BK0028"],"gpt_icon":0},{"id":"2555089512","title":"全市场独家品种·创新药ETF天弘(517380)飙涨4.56%，涨幅位居全市场第一","url":"https://stock-news.laohu8.com/highlight/detail?id=2555089512","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555089512?lang=zh_cn&edition=full","pubTime":"2025-07-29 11:36","pubTimestamp":1753760164,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c07cc57ab6b694d79365e96e00510786","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["07226","MU","CYB","300347","MUCmain","03347","GSK.UK","LU0719512351.SGD","LU1997245094.SGD","LU0405327148.USD","515120","603259","BK0012","600276","CNHmain","BK4512","MCNHmain","LU1997245177.USD","BK4532","09939","UCmain","01276","CXO","LU1655091616.SGD","159992","BK4553","HSCEI","IE00B19Z3B42.SGD","BK0229","159982","06978","BK0060","159938","02359","CXO.AU","FDN","399300","BK4614","LU1146622755.USD","YANG","GSK","LU0082616367.USD","BK0077","LU2286300806.USD","159217","HSTECH","LU1969619763.USD","BK4543","300725","LU1829250122.USD"],"gpt_icon":0},{"id":"2555108668","title":"港股异动 | 泰格医药(03347.HK)涨超3% 附属拟购买日本MICRON 56.37%股权 深度拓展日本及亚太业务布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2555108668","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555108668?lang=zh_cn&edition=full","pubTime":"2025-07-29 10:37","pubTimestamp":1753756679,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2286300806.USD","BK0216","BK4554","LU1820825898.SGD","BK4588","BK4585","300347","MU","GB00BDT5M118.USD","BK4533","IE00B19Z3B42.SGD","LU2250418816.HKD","BK4532","BK4553","LU0719512351.SGD","LU1366333091.USD","IE0002270589.USD","LU0157215616.USD","LU2089985449.USD","LU2048586759.USD","BK1576","LU0642271901.SGD","LU1146622755.USD","LU1267930813.SGD","LU0889566641.SGD","BK4579","LU0056508442.USD","LU0792757196.USD","BK1583","BK1141","LU2360106780.USD","BK4575","BK0174","BK4527","BK4566","LU1316542783.SGD","BK0028","BK4605","LU0127658192.USD","IE00B19Z3581.USD","BK4512","LU0081259029.USD","LU0082616367.USD","IE00B7SZLL34.SGD","LU0274383776.USD","BK4141","BK0077","LU2211815571.USD","03347","LU1852331112.SGD"],"gpt_icon":0},{"id":"2555870724","title":"泰格医药宣布收购日本CRO公司Micron","url":"https://stock-news.laohu8.com/highlight/detail?id=2555870724","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555870724?lang=zh_cn&edition=full","pubTime":"2025-07-29 08:28","pubTimestamp":1753748936,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0077","BK4527","03347","BK4532","LU1366333091.USD","IE0002270589.USD","LU0719512351.SGD","IE00B7SZLL34.SGD","LU0081259029.USD","LU2048586759.USD","300347","BK0216","LU0056508442.USD","LU2360106780.USD","LU0157215616.USD","LU2250418816.HKD","BK4605","LU0792757196.USD","BK0028","MU","BK4585","BK4575","BK4588","IE00B19Z3581.USD","LU0127658192.USD","LU1146622755.USD","LU2089985449.USD","BK4553","LU1267930813.SGD","LU0642271901.SGD","BK1576","BK1583","LU0889566641.SGD","BK1141","BK4141","LU0082616367.USD","BK4543","LU1852331112.SGD","LU2211815571.USD","BK0174","BK4579","BK4533","BK4566","IE00B19Z3B42.SGD","LU1820825898.SGD","LU0274383776.USD","LU1316542783.SGD","BK4512","LU2286300806.USD","GB00BDT5M118.USD"],"gpt_icon":0},{"id":"2554772397","title":"泰格医药(03347.HK)股东曹晓春拟减持公司股份不超过300万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2554772397","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554772397?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:24","pubTimestamp":1753709075,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159982","BK1141","LU1820825898.SGD","BK1576","300347","BK0028","LU1146622755.USD","BK0216","BK0174","BK1583","399300","BK0077","03347"],"gpt_icon":0},{"id":"2554774269","title":"泰格医药(03347)附属拟2347.71万元购买日本MICRON 56.37%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2554774269","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554774269?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:05","pubTimestamp":1753707943,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药 发布公告，公司全资附属公司株式会社泰格医药日本与日本MICRON╱株式会社マイクロン原股东签署《股份转让协议》购买其持有的部分MICRON股权，本次转让完成后，日本泰格将持有MICRON 56.37%股权。购买价格为4.84亿日元，折合人民币约2347.71万元。据悉，MICRON成立于2005年，总部位于日本东京，员工人数超过160人，是一家专注于医学影像及临床试验服务的CRO公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B19Z3B42.SGD","LU1366333091.USD","BK4532","BK4585","LU0157215616.USD","LU0792757196.USD","GB00BDT5M118.USD","LU1852331112.SGD","LU0274383776.USD","300347","LU2360106780.USD","03347","LU0719512351.SGD","BK1576","BK4605","IE00B7SZLL34.SGD","BK4512","BK4575","LU1267930813.SGD","BK4553","BK4527","LU2286300806.USD","LU0889566641.SGD","LU2089985449.USD","BK0174","BK4566","BK4588","IE0002270589.USD","LU0642271901.SGD","BK1141","BK1583","BK4533","LU0082616367.USD","LU1316542783.SGD","BK4141","LU2048586759.USD","BK0216","LU0127658192.USD","LU2250418816.HKD","LU1820825898.SGD","BK0077","LU0056508442.USD","BK0028","BK4543","LU0081259029.USD","LU1146622755.USD","LU2211815571.USD","BK4579","BK4554"],"gpt_icon":1},{"id":"2554774816","title":"泰格医药最新公告：持股5%以上股东曹晓春拟减持不超过300万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2554774816","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554774816?lang=zh_cn&edition=full","pubTime":"2025-07-28 20:41","pubTimestamp":1753706464,"startTime":"0","endTime":"0","summary":"泰格医药(300347.SZ)公告称，公司持股5%以上股东、董事及总经理曹晓春计划自公告披露之日起15个交易日之后的3个月内，以集中竞价和/或大宗交易方式减持公司股份不超过300万股，占剔除回购专户股份数后公司总股本的0.3508%，占公司A股总股本的0.4098%。减持原因为偿还债务及利息，降低质押融资风险。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072800031215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1576","BK0028","BK1141","LU1820825898.SGD","300347","LU1146622755.USD","BK0174","BK1583","03347","BK0077"],"gpt_icon":0},{"id":"2554776618","title":"易方达基金减持泰格医药(03347)42.41万股 每股作价约50.43港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554776618","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554776618?lang=zh_cn&edition=full","pubTime":"2025-07-28 19:22","pubTimestamp":1753701756,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，7月22日，易方达基金减持泰格医药(03347)42.41万股，每股作价50.425港元，总金额约为2138.52万港元。减持后最新持股数目为1447.87万股，持股比例为11.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322742.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1820825898.SGD","BK1141","BK0174","BK0216","03347","BK1576","300347","BK0028","BK1583","LU1146622755.USD","BK0077"],"gpt_icon":0},{"id":"2553328230","title":"易方达基金增持泰格医药(03347)37万股 每股作价约49.98港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553328230","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553328230?lang=zh_cn&edition=full","pubTime":"2025-07-22 18:56","pubTimestamp":1753181767,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月17日，易方达基金增持泰格医药(03347)37万股，每股作价49.9795港元，总金额约为1849.24万港元。增持后最新持股数目为1494.68万股，持股比例为12.14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1320629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0174","BK1141","BK0028","LU1820825898.SGD","BK0216","LU1146622755.USD","300347","BK1576","03347","BK1583","BK0077"],"gpt_icon":0},{"id":"2552460060","title":"泰格医药：完成开源大模型DeepSeek-R1本地化部署","url":"https://stock-news.laohu8.com/highlight/detail?id=2552460060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552460060?lang=zh_cn&edition=full","pubTime":"2025-07-18 20:51","pubTimestamp":1752843083,"startTime":"0","endTime":"0","summary":"证券之星消息，泰格医药07月17日在投资者关系平台上答复投资者关心的问题。公司已于2025年2月完成开源大模型DeepSeek-R1的本地化部署。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800036335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300347","03347"],"gpt_icon":0},{"id":"2552075921","title":"泰格医药最新公告：出售参股公司礼新医药股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2552075921","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552075921?lang=zh_cn&edition=full","pubTime":"2025-07-17 17:10","pubTimestamp":1752743407,"startTime":"0","endTime":"0","summary":"泰格医药(300347.SZ)公告称，公司通过所属投资平台杭州泰格股权投资合伙企业（有限合伙）持有礼新医药科技（上海）有限公司3.41%的股权。礼新医药拟将95.09%股权转让给正大制药投资（北京）集团有限公司。公司拟同意标的公司的出售安排，配合将泰格股权直接持有的礼新医药全部股权以约3,411万美元转让给买方。本次交易完成后，公司将不再持有礼新医药的股权。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071700026626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","300347","BK0174","BK1515","159938","LU1146622755.USD","BK0028","BK1576","BK0077","BK1161","BK1574","BK1583","BK1141","LU1820825898.SGD","BK0216","03347"],"gpt_icon":0},{"id":"2551115961","title":"CRO概念盘中跳水，泰格医药跌0.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551115961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551115961?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:36","pubTimestamp":1752629773,"startTime":"0","endTime":"0","summary":"07月16日，CRO概念盘中跳水，截至09点36分，CRO概念整体指数下跌0.84%，报507.430点。从个股上来看，该概念的成分股中，泰格医药跌0.10%，谱尼测试跌幅居前。从资金上来看，截止发稿，CRO概念主力净流入为-969.25万，其中美迪西受到资金热捧，主力净流入1356.02万；拉长时间线来看，该板块近20日主力资金净流入-28.46亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093613a6ac36dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093613a6ac36dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0174","LU1820825898.SGD","BK0028","LU1146622755.USD","BK0216","300347","688202","BK0077"],"gpt_icon":0},{"id":"2549567224","title":"健康中国概念盘中拉升，泰格医药涨3.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549567224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549567224?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:35","pubTimestamp":1751938552,"startTime":"0","endTime":"0","summary":"07月08日，健康中国概念盘中拉升，截至09点35分，健康中国概念整体指数上涨0.52%，报1208.970点。从个股上来看，该概念的成分股中，泰格医药涨3.70%，百洋医药、汉商集团、冠昊生物涨幅居前。从资金上来看，截止发稿，健康中国概念主力净流入为-4337.23万，其中爱尔眼科受到资金热捧，主力净流入854.75万；拉长时间线来看，该板块近20日主力资金净流入-107.94亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708093552953a33d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708093552953a33d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0174","600774","BK0028","BK0239","LU1820825898.SGD","BK0216","LU1146622755.USD","300347","BK0209","BK0077"],"gpt_icon":0},{"id":"2548965877","title":"中证万得生物科技指数上涨2.24%，前十大权重包含泰格医药等","url":"https://stock-news.laohu8.com/highlight/detail?id=2548965877","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548965877?lang=zh_cn&edition=full","pubTime":"2025-07-03 17:29","pubTimestamp":1751534973,"startTime":"0","endTime":"0","summary":"数据统计显示，中证万得生物科技指数近一个月上涨3.77%，近三个月上涨2.51%，年至今上涨10.41%。据了解，中证万得生物科技指数选取主营业务涉及生物科技产业的具备较高流动性及市值代表性的上市公司证券作为指数样本，为投资者提供更多样化的投资标的。从中证万得生物科技指数持仓样本的行业来看，医药卫生占比97.81%、主要消费占比1.19%、原材料占比1.00%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/03172951463034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0077","BK1576","LU1146622755.USD","03347","BK0028","300347","BK0216","159837","BK1583","LU1820825898.SGD","BK1141","BK0174"],"gpt_icon":0},{"id":"2548663879","title":"泰格医药：公司及所投基金对创新生物制药及医疗器械初创企业进行少数股权投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2548663879","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548663879?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:30","pubTimestamp":1751531438,"startTime":"0","endTime":"0","summary":"证券之星消息，泰格医药07月03日在投资者关系平台上答复投资者关心的问题。截至2024年12月31日，公司对外投资组合包括医疗行业的 187 家公司和 54 只基金。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300026255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK0174","BK1141","BK1100","09997","BK0028","BK1574","BK0077","BK0216","159883","LU1820825898.SGD","BK1576","LU1146622755.USD","BK1222","300347","09996","03347"],"gpt_icon":0},{"id":"2547030203","title":"【创新药板块探底回升，昭衍新药涨停】创新药板块探底回升，昭衍新药涨停，艾迪药业涨超6%，泰格医药、凯莱英、舒泰神跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2547030203","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547030203?lang=zh_cn&edition=full","pubTime":"2025-06-30 11:21","pubTimestamp":1751253664,"startTime":"0","endTime":"0","summary":"创新药板块探底回升，昭衍新药涨停，艾迪药业涨超6%，泰格医药、凯莱英、舒泰神跟涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/30112151382528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0046","06821","BK0216","BK0028","06127","BK1576","03347","06978","BK0132","LU1328615791.USD","159992","LU1146622755.USD","BK1191","BK1583","300347","BK0077","BK1574","300204","BK0174","BK0262","603127","LU1820825898.SGD","BK1141","688488","BK0239","BK1161","002821"],"gpt_icon":0},{"id":"2545239035","title":"中证万得生物科技指数上涨1.36%，前十大权重包含泰格医药等","url":"https://stock-news.laohu8.com/highlight/detail?id=2545239035","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545239035?lang=zh_cn&edition=full","pubTime":"2025-06-24 23:19","pubTimestamp":1750778397,"startTime":"0","endTime":"0","summary":"数据统计显示，中证万得生物科技指数近一个月上涨3.36%，近三个月上涨1.48%，年至今上涨6.77%。据了解，中证万得生物科技指数选取主营业务涉及生物科技产业的具备较高流动性及市值代表性的上市公司证券作为指数样本，为投资者提供更多样化的投资标的。从中证万得生物科技指数持仓样本的行业来看，医药占比73.29%、医疗占比24.44%、家庭与个人用品占比1.25%、化工占比1.01%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/24231951284143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1146622755.USD","BK0028","300347","BK0174","BK0077","BK1141","03347","LU1820825898.SGD","BK1576","BK1583","159837","BK0216"],"gpt_icon":0},{"id":"2544146609","title":"泰格医药：2024年7月，公司完成了对日本CRO公司Medical Edge Co., Ltd.的收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2544146609","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544146609?lang=zh_cn&edition=full","pubTime":"2025-06-20 16:01","pubTimestamp":1750406462,"startTime":"0","endTime":"0","summary":"证券之星消息，泰格医药06月20日在投资者关系平台上答复投资者关心的问题。泰格医药回复：投资者您好，2024年7月，公司完成了对日本CRO公司Medical Edge Co., Ltd.的收购以进一步加强了在日本及亚太地区数据管理、统计分析和临床数据信息系统服务的布局；截至2024年末，公司日本本土临床服务团队增加至21人，有10个在日本执行的国际多中心临床试验项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062000020659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","300347","BK0077","BK0216","03347","LU1146622755.USD","LU1820825898.SGD","BK1576","BK0028","BK1583","BK1141"],"gpt_icon":0},{"id":"2544992688","title":"泰格医药新注册《基于Word的翻译文档字数统计工具软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2544992688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544992688?lang=zh_cn&edition=full","pubTime":"2025-06-18 02:02","pubTimestamp":1750183340,"startTime":"0","endTime":"0","summary":"证券之星消息，近日泰格医药（300347）新注册了《基于Word的翻译文档字数统计工具软件V1.0》项目的软件著作权。今年以来泰格医药新注册软件著作权5个，较去年同期减少了44.44%。结合公司2024年年报财务数据，2024年公司在研发方面投入了2.38亿元，同比减8.86%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061800000390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300347","BK0216","03347","LU1820825898.SGD","BK0077","BK1576","BK0028","BK0174","LU1146622755.USD","BK1141","BK1583"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1754339869171,"stockEarnings":[{"period":"1week","weight":0.0476},{"period":"1month","weight":0.231},{"period":"3month","weight":0.4486},{"period":"6month","weight":0.3442},{"period":"1year","weight":0.2129},{"period":"ytd","weight":0.2187}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":0.032},{"period":"3month","weight":0.0806},{"period":"6month","weight":0.1096},{"period":"1year","weight":0.2334},{"period":"ytd","weight":0.0691}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州泰格医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"0人","perCapita":"--","listingDate":"2012-08-17","address":"浙江省杭州市滨江区西兴街道聚工路19号8幢20层2001-2010室","registeredCapital":"86102万元","survey":" 杭州泰格医药科技股份有限公司的主营业务是为新药研发提供临床试验全过程专业服务的合同研究组织（CRO），为全球医药和医疗器械创新企业提供全面而综合的临床研究解决方案。公司的主要产品是临床运营、临床药理、注册与法规事务、科学事务、医学翻译、药物警戒、真实世界研究、第三方稽查与培训、数据管理及统计分析、临床试验现场管理、受试者招募、医学影像以及实验室。","listedPrice":37.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.5","shortVersion":"4.34.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(300347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(300347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,300347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(300347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(300347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}